| Product Code: ETC7918569 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pharmacogenetic Testing Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Latvia Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Latvia Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing focus on personalized medicine and precision healthcare |
4.2.3 Government initiatives promoting the adoption of pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for pharmacogenetic tests |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenetic testing |
5 Latvia Pharmacogenetic Testing Market Trends |
6 Latvia Pharmacogenetic Testing Market, By Types |
6.1 Latvia Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Latvia Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Latvia Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Latvia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Latvia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Latvia Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Latvia Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Latvia Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Latvia Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Latvia Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Latvia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Latvia Pharmacogenetic Testing Market Export to Major Countries |
7.2 Latvia Pharmacogenetic Testing Market Imports from Major Countries |
8 Latvia Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare professionals trained in pharmacogenetic testing |
8.2 Adoption rate of pharmacogenetic testing in clinical practice |
8.3 Number of research studies and publications on pharmacogenetic testing in Latvia |
9 Latvia Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Latvia Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Latvia Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Latvia Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here